REFINE - a randomised control trial testing reduced intensity immunotherapy across different cancers

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2022
This article has no abstract
Epistemonikos ID: f09fed1dc3fcc154e2e371615880e2b6f7f51639
First added on: Jan 17, 2025